» Articles » PMID: 3954253

Assessment of Interlobar Variation of Bronchoalveolar Lavage Cellular Differentials in Interstitial Lung Diseases

Overview
Specialty Pulmonary Medicine
Date 1986 Mar 1
PMID 3954253
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Alveolitis is thought to precede permanent lung derangement in a variety of interstitial lung diseases (ILD). Bronchoalveolar lavage (BAL) cell differentials can be used to evaluate the intensity of alveolitis, whereas clinical, roentgenographic, and functional studies are insensitive monitors of lung inflammation. As ILD is generally diffuse, unilobar lavage is widely used and presumed to gauge overall lung inflammation. Consistency of lobe to lobe cell differential findings has not been systematically addressed. We analyzed 53 bilateral lobar lavages (right middle lobe and lingula) in 34 patients with sarcoidosis, idiopathic pulmonary fibrosis-collagen vascular disease (IPF-CV) and a group of mixed interstitial diseases. Cellular differentials from each lobe were independently assessed and compared. The sarcoid group, with predominantly T-lymphocytes in BAL, showed excellent interlobar correlation (r = 0.92, p less than 0.001), with only 17% showing a discrepancy of greater than 10% in percentage of T-lymphocytes. In contrast, the IPF-CV group, with predominantly neutrophils in BAL, showed good interlobar correlation (r = 0.79; p less than 0.01), but 35% had a greater than 10% discrepancy in percentage of neutrophils. Finally, the mixed group, with lymphocytes as the predominant cell in BAL, showed poor interlobar correlation (r = 0.58; p greater than 0.10), with 42% showing a greater than 10% discrepancy in percentage of lymphocytes. These results were not explicable on the basis of differences in volume of lavage fluid or total cells recovered, these parameters being remarkably consistent between lobes in the 3 patient groups and in a control group of 8 subjects without ILD. The chest roentgenogram was markedly insensitive to lavage interlobar variation.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.

Koda K, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K Sci Rep. 2021; 11(1):1682.

PMID: 33462365 PMC: 7814131. DOI: 10.1038/s41598-021-81313-5.


Aspiration techniques for bronchoalveolar lavage in translational respiratory research: Paving the way to develop novel therapeutic moieties.

Dua K, Shukla S, Hansbro P J Biol Methods. 2019; 4(3):e73.

PMID: 31453230 PMC: 6706109. DOI: 10.14440/jbm.2017.174.


Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients.

Brownback K, Simpson S Ann Thorac Med. 2013; 8(3):153-9.

PMID: 23922610 PMC: 3731857. DOI: 10.4103/1817-1737.114302.


Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.

Divekar A, Khanna D, Abtin F, Maranian P, Saggar R, Saggar R Clin Immunol. 2011; 141(3):293-303.

PMID: 22015344 PMC: 3221795. DOI: 10.1016/j.clim.2011.08.010.


[Bronchoalveolar lavage].

Totsch M, Guzman J, Theegarten D, Schmid K, Costabel U Pathologe. 2007; 28(5):346-53.

PMID: 17661044 DOI: 10.1007/s00292-007-0926-6.